DIANA LEVINA

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine BROOKLYN, NY NPI 1114017472

General Payments — all program years on this page

$7,685.02

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,900.63 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,900.6315

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $525.004
Boehringer Ingelheim Pharmaceuticals, Inc. $489.584
Lilly USA, LLC $246.252
Acerta Pharma LLC $244.782
Ardelyx, Inc. $140.051
Alkermes, Inc. $130.001
AIMMUNE THERAPEUTICS, INC. $124.971

By program year

Program yearAmountRecords
2018 $1,051.129
2019 $973.058
2020 $694.466
2021 $744.296
2022 $1,126.5610
2023 $1,194.919
2024 $1,900.6315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105400208 AstraZeneca Pharmaceuticals LP $119.78 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105504736 AstraZeneca Pharmaceuticals LP $125.00 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111633428 Amgen Inc. $125.00 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111633430 Amgen Inc. $125.00 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111633432 Amgen Inc. $125.00 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117309583 Amgen Inc. $150.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876129 Boehringer Ingelheim Pharmaceuticals, Inc. $114.58 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876131 Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876133 Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117876135 Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120541267 Alkermes, Inc. $130.00 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136153102 Lilly USA, LLC $125.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136153104 Lilly USA, LLC $121.25 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146692108 Ardelyx, Inc. $140.05 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146967817 AIMMUNE THERAPEUTICS, INC. $124.97 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.